Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels: Anti-Müllerian hormone in poor responders in assisted reproductive treatment

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 8, 2012, Pages 797-802

  Celik, Handan ^a,b   Bıldırcın, Devran ^a   Güven, Davut ^a   Cetinkaya, Mehmet B ^a   Alper, Tayfun ^a   Batuoğlu, A Sertaç ^a  

^a IVF Center   (Turkey)

^b NONE   (Turkey)

Author keywords

Anti M llerian hormone; Diminished ovarian reserve; Follicle stimulating hormone

Indexed keywords

FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DIMINISHED OVARIAN RESERVE; EMBRYO TRANSFER; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY DISEASE; OVARY FUNCTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

EID: 84867052364     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9794-y     Document Type: Article

References (22)

1. Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril. 2005;84:555-69.
2. Scott RT, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril. 1995;63:1-11.
3. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002;77:328-36.
4. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685-718.
5. Fiçicioǧlu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006;85:592-6.
6. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab. 1996;81:571-76.
7. Sahmay S, Cetin M, Ocal P, Kaleli S, Senol H, Birol F, Irez T. Serum anti-müllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patient. Reprod Med Biol. 2011;10:9-14.
8. Van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, Jong FH, et al. Serum antimullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065-71.
9. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Antimullerian hormone and its role in ovarian function. Mol Cell Endocrinol. 2003;211:85-90.
10. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio CA, et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16:113-30.
11. Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. The role of antimullerian hormone in predicting outcome after IVF: comparison with antral follicle count. Fertil Steril. 2009;91:705-14.
12. La Marca A, Volpe A. Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol. 2006;64:603-10.
13. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91:4057-63.
14. Garcia JE, Jones GS, Acosta AA, Wright G HMG/hCGfollicular maturation for oocytes aspiration: phase II, 1981. Fertil Steril. 1983;39:174-9.
15. Raga F, Bonilla-Musoles F, Casan EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod. 1999;14:1431-4.
16. Land J, Yarmolinskaya M, Dumoulin J, Evers J. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril. 1996;65:961-5.
17. Karande V, Gleicher N. A rational approach to the management of low responders in IVF. Hum Reprod. 1999;14:1744-9.
18. Ferraretti AP, La Marca A, Fauser BJCM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616-24.
19. Buyuk E, Seifer DB, Younger J, Grazi RV, Lieman HM. Random anti-Müllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels. Fertil Steril. 2011;95:2369-72.
20. Coccia ME, Rizzello F. Ovarian reserve. Ann N Y Acad Sci. 2008;1127:27-30.
21. Gleicher N, Weghofer A, Barad DH. Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril. 2010;94:2824-7.
22. Barad DH, Weghofer A, Gleicher N. Comparing anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril. 2009;91:1553-5.